Form 8-K - Current report:
SEC Accession No. 0001193125-25-025663
Filing Date
2025-02-13
Accepted
2025-02-13 09:00:18
Documents
15
Period of Report
2025-02-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d892128d8k.htm   iXBRL 8-K 24977
2 EX-99.1 d892128dex991.htm EX-99.1 9195
6 GRAPHIC g892128g0213080258357.jpg GRAPHIC 2257
  Complete submission text file 0001193125-25-025663.txt   159430

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plrx-20250213.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20250213_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20250213_pre.xml EX-101.PRE 10814
17 EXTRACTED XBRL INSTANCE DOCUMENT d892128d8k_htm.xml XML 3517
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 25617435
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)